- Home
- NDLS vs SCNX Comparison
NDLS vs SCNX Comparison
Compare NDLS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.60
N/A
Current Price
$0.51
Company Overview
Basic Information| Metric | NDLS | SCNX |
|---|---|---|
| Founded | 1995 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 24.8M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NDLS | SCNX |
|---|---|---|
| Price | $0.60 | $0.51 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 644.9K | ★ 1.7M |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $494,087,000.00 | $653,391.00 |
| Revenue This Year | $2.18 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 207.88 |
| 52 Week Low | $0.55 | $0.46 |
| 52 Week High | $1.74 | $8.19 |
Technical Indicators
Market Signals| Indicator | NDLS | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 39.24 |
| Support Level | $0.76 | $0.54 |
| Resistance Level | $1.08 | $0.75 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 0.48 | 1.45 |
Price Performance
Historical Comparison NDLS
SCNX
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.